Published in J Bacteriol on June 01, 2000
Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant. BMC Microbiol (2008) 0.98
Characterization of Mycobacterium leprae RecA intein, a LAGLIDADG homing endonuclease, reveals a unique mode of DNA binding, helical distortion, and cleavage compared with a canonical LAGLIDADG homing endonuclease. J Biol Chem (2009) 0.77
Biochemistry of homologous recombination in Escherichia coli. Microbiol Rev (1994) 9.93
Protein splicing converts the yeast TFP1 gene product to the 69-kD subunit of the vacuolar H(+)-adenosine triphosphatase. Science (1990) 3.60
Molecular structure of a gene, VMA1, encoding the catalytic subunit of H(+)-translocating adenosine triphosphatase from vacuolar membranes of Saccharomyces cerevisiae. J Biol Chem (1990) 3.47
Intervening sequences in an Archaea DNA polymerase gene. Proc Natl Acad Sci U S A (1992) 2.92
Transformation of mycobacterial species using hygromycin resistance as selectable marker. Microbiology (1994) 2.55
rpsL+: a dominant selectable marker for gene replacement in mycobacteria. Mol Microbiol (1995) 2.49
Compilation and analysis of intein sequences. Nucleic Acids Res (1997) 2.46
Novel structure of the recA locus of Mycobacterium tuberculosis implies processing of the gene product. J Bacteriol (1991) 2.43
Protein splicing in the maturation of M. tuberculosis recA protein: a mechanism for tolerating a novel class of intervening sequence. Cell (1992) 2.35
Evidence of selection for protein introns in the recAs of pathogenic mycobacteria. EMBO J (1994) 2.04
Protein splicing and autoproteolysis mechanisms. Curr Opin Chem Biol (1997) 1.60
The role of ribosomal RNAs in macrolide resistance. Mol Microbiol (1997) 1.53
SOS-regulated proteins in translesion DNA synthesis and mutagenesis. Trends Biochem Sci (1995) 1.34
Protein splicing in trans by purified N- and C-terminal fragments of the Mycobacterium tuberculosis RecA intein. Proc Natl Acad Sci U S A (1998) 1.25
The ins and outs of protein splicing elements. Mol Microbiol (1994) 1.19
Construction and complementation of a recA deletion mutant of Mycobacterium smegmatis reveals that the intein in Mycobacterium tuberculosis recA does not affect RecA function. Mol Microbiol (1998) 1.16
Investigation of mycobacterial recA function: protein introns in the RecA of pathogenic mycobacteria do not affect competency for homologous recombination. Mol Microbiol (1998) 1.08
Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S ribosomal RNA. Nucleic Acids Res (1989) 19.85
Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol (1993) 18.91
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet (1993) 16.75
Detection and identification of mycobacteria by amplification of rRNA. J Clin Microbiol (1990) 12.41
Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory. J Clin Microbiol (1993) 9.76
Towards a phylogeny and definition of species at the molecular level within the genus Mycobacterium. Int J Syst Bacteriol (1990) 7.65
Differentiation of Mycobacterium species by direct sequencing of amplified DNA. J Gen Microbiol (1990) 7.33
Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods. J Clin Microbiol (1996) 5.80
Mammalian and bacterial sugar transport proteins are homologous. Nature (1987) 4.46
Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol Microbiol (1993) 3.83
Vaccination against tuberculosis by DNA injection. Nat Med (1996) 3.76
Brief report: disseminated osteomyelitis from Mycobacterium ulcerans after a snakebite. N Engl J Med (1993) 3.75
Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob Agents Chemother (1994) 3.28
16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory. J Clin Microbiol (2006) 3.25
Elimination of contaminating DNA within polymerase chain reaction reagents: implications for a general approach to detection of uncultured pathogens. J Clin Microbiol (1993) 3.22
Microheterogeneity within rRNA of Mycobacterium gordonae. J Clin Microbiol (1992) 3.20
Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1999) 3.16
The Shrunken gene on chromosome 9 of Zea mays L is expressed in various plant tissues and encodes an anaerobic protein. Mol Gen Genet (1986) 3.09
Therapy of tuberculosis in mice by DNA vaccination. Nature (1999) 2.99
Protein splicing elements: inteins and exteins--a definition of terms and recommended nomenclature. Nucleic Acids Res (1994) 2.97
Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother (1996) 2.92
Genomic analysis reveals variation between Mycobacterium tuberculosis H37Rv and the attenuated M. tuberculosis H37Ra strain. Infect Immun (1999) 2.84
Isolation and characterization of a unique group of slowly growing mycobacteria: description of Mycobacterium lentiflavum sp. nov. J Clin Microbiol (1996) 2.66
Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov. Int J Syst Bacteriol (1995) 2.50
rpsL+: a dominant selectable marker for gene replacement in mycobacteria. Mol Microbiol (1995) 2.49
Phylogenetic analysis and identification of different serovars of Mycobacterium intracellulare at the molecular level. FEMS Microbiol Lett (1990) 2.47
Novel structure of the recA locus of Mycobacterium tuberculosis implies processing of the gene product. J Bacteriol (1991) 2.43
Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy. Int J Syst Evol Microbiol (2001) 2.38
Protein splicing in the maturation of M. tuberculosis recA protein: a mechanism for tolerating a novel class of intervening sequence. Cell (1992) 2.35
A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. J Infect Dis (1998) 2.34
Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon. Infect Immun (1998) 2.34
Genetic heterogeneity within Mycobacterium fortuitum complex species: genotypic criteria for identification. J Clin Microbiol (1992) 2.30
The nucleotide sequence of the promoter, 16S rRNA and spacer region of the ribosomal RNA operon of Mycobacterium tuberculosis and comparison with Mycobacterium leprae precursor rRNA. J Gen Microbiol (1992) 2.28
Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies. J Clin Microbiol (1997) 2.24
Frequent contamination of Taq polymerase with DNA. Clin Chem (1990) 2.23
Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance. Antimicrob Agents Chemother (1994) 2.23
Identification of mycobacteria by PCR-based sequence determination of the 32-kilodalton protein gene. J Clin Microbiol (1994) 2.20
Species identification of mycobacteria using rDNA sequencing. Methods Mol Biol (1998) 2.19
Evidence of selection for protein introns in the recAs of pathogenic mycobacteria. EMBO J (1994) 2.04
Ribosomal DNA sequencing for identification of aerobic gram-positive rods in the clinical laboratory (an 18-month evaluation). J Clin Microbiol (2003) 2.02
Semantide- and chemotaxonomy-based analyses of some problematic phenotypic clusters of slowly growing mycobacteria, a cooperative study of the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1996) 2.02
Comparison of conventional and molecular methods for identification of aerobic catalase-negative gram-positive cocci in the clinical laboratory. J Clin Microbiol (2004) 1.96
1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology (1981) 1.95
Diagnosis of mycobacterial infections by nucleic acid amplification: 18-month prospective study. J Clin Microbiol (1996) 1.94
Fitness of antibiotic-resistant microorganisms and compensatory mutations. Nat Med (1998) 1.94
Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis. Infect Immun (1997) 1.91
Regulation of the inducible acetamidase gene of Mycobacterium smegmatis. Microbiology (1997) 1.86
Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients. J Clin Microbiol (1992) 1.82
Burden of unidentifiable mycobacteria in a reference laboratory. J Clin Microbiol (2001) 1.79
Mycobacterium lentiflavum: an etiologic agent of cervical lymphadenitis. Clin Infect Dis (1997) 1.79
Mycobacterium intermedium sp. nov. Int J Syst Bacteriol (1993) 1.75
A mycobacterial 65-kD heat shock protein induces antigen-specific suppression of adjuvant arthritis, but is not itself arthritogenic. J Exp Med (1990) 1.75
Transgenic mice selectively lacking MHC class II (I-E) antigen expression on B cells: an in vivo approach to investigate Ia gene function. Cell (1987) 1.74
Mycobacterium interjectum, a new species isolated from a patient with chronic lymphadenitis. J Clin Microbiol (1993) 1.73
Mycobacterium branderi sp. nov., a new potential human pathogen. Int J Syst Bacteriol (1995) 1.71
Lipoprotein processing is required for virulence of Mycobacterium tuberculosis. Mol Microbiol (2004) 1.67
Introducing mutations into a chromosomal rRNA gene using a genetically modified eubacterial host with a single rRNA operon. Mol Microbiol (1996) 1.65
Ribosomal and non-ribosomal resistance to oxazolidinones: species-specific idiosyncrasy of ribosomal alterations. Mol Microbiol (2002) 1.64
Characterization of mycobacterial isolates phylogenetically related to, but different from Mycobacterium simiae. J Clin Microbiol (1997) 1.64
Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. J Infect Dis (1996) 1.61
Structural basis for selectivity and toxicity of ribosomal antibiotics. EMBO Rep (2001) 1.61
Recognition of a mycobacteria-specific epitope in the 65-kD heat-shock protein by synovial fluid-derived T cell clones. J Exp Med (1990) 1.57
Species-specific assessment of Mycobacterium leprae in skin biopsies by in situ hybridization and polymerase chain reaction. Lab Invest (1992) 1.55
Cloning and sequencing of the gene which encodes the highly inducible acetamidase of Mycobacterium smegmatis. J Gen Microbiol (1993) 1.55
Lack of rifabutin resistance with prophylaxis for disseminated Mycobacterium avium complex. Lancet (1994) 1.55
The role of ribosomal RNAs in macrolide resistance. Mol Microbiol (1997) 1.53
A new agent of mycobacterial lymphadenitis in children: Mycobacterium heidelbergense sp. nov. J Clin Microbiol (1997) 1.52
Mycobacterium tuberculosis nucleic acid probes for rapid diagnosis. Lancet (1993) 1.51
Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother (1996) 1.51
RecA-Mediated gene conversion and aminoglycoside resistance in strains heterozygous for rRNA. Antimicrob Agents Chemother (1999) 1.51
Genetic interrelationships of proteolytic Clostridium botulinum types A, B, and F and other members of the Clostridium botulinum complex as revealed by small-subunit rRNA gene sequences. Antonie Van Leeuwenhoek (1994) 1.50
Tumour necrosis factor-alpha (TNF-alpha) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions. Clin Exp Immunol (1995) 1.50
Mycobacteriosis due to Mycobacterium genavense in six pet birds. J Clin Microbiol (1993) 1.49
Protection against tuberculosis by a plasmid DNA vaccine. Vaccine (1997) 1.48
Immunological activity of a 14-kilodalton recombinant protein of Mycobacterium tuberculosis H37Rv. Infect Immun (1987) 1.48
Heterologous expression of the 65-kilodalton antigen of Mycobacterium leprae and murine T-cell responses to the gene product. Infect Immun (1988) 1.48